Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Terapie
    komórkami macierzystymi

    Terapie komórkami macierzystymi

    Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).

    Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.

    Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.

    Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.

    Data aktualizacji: 06.2026

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
    Lp. Źródło Typ źródła Wskazanie Obszar medycyny Rok podania Terapia Kraj Wiek odbiorcy
    8001 Apheresis Autologous Small Cell Ovarian Carcinoma Hematology 2016 Standard Therapy Germany 18
    8002 Apheresis Allogeneic T Cell Lymphoma/ Nos – Not Otherwise Specified Hematology 2016 Standard Therapy Poland 55
    8003 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 19
    8004 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 21
    8005 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 41
    8006 Apheresis Allogeneic T-Cell Leukemia/Lymphoma Hematology 2016 Standard Therapy Poland 31
    8007 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 48
    8008 Apheresis Allogeneic T-Cell Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 24
    8009 Apheresis Autologous T-Cell-Lymphoma Hematology 2016 Standard Therapy Germany 55
    8010 Apheresis Autologous T-Cell-Lymphoma Hematology 2016 Standard Therapy Germany 33
    8011 Apheresis Allogeneic T-Cell-Prolymphocytic Leukemia Hematology 2016 Standard Therapy Poland 61
    8012 Apheresis Allogeneic Wiskott-Aldrich Syndrome Hematology 2016 Standard Therapy Poland 1
    8013 Apheresis Allogeneic X-Linked Lymphoproliferative Disease Hematology 2016 Standard Therapy Poland 12
    8014 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 1
    8015 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 11
    8016 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 51
    8017 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 6
    8018 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 13
    8019 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy; Encephalopathy Neurology 2015 Experimental Therapy Poland 23
    8020 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61
    8021 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61
    8022 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 56
    8023 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 51
    8024 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 65
    8025 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 60
    8026 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 52
    8027 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 59
    8028 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61
    8029 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 58
    8030 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61
    8031 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 62
    8032 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 26
    8033 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 27
    8034 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 63
    8035 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 67
    8036 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 37
    8037 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 58
    8038 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 46
    8039 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 48
    8040 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61
    8041 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 54
    8042 Cord Tissue Allogeneic – Unrelated Anterior Ischemic Optic Neuropathy Ophthalmology 2015 Experimental Therapy Poland 54
    8043 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 5
    8044 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 3
    8045 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 12
    8046 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 6
    8047 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 4
    8048 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 5
    8049 Cord Tissue Allogeneic – Unrelated Autism Neurology 2015 Experimental Therapy Poland 8
    8050 Cord Tissue Allogeneic – Unrelated Bilateral Blindness Ophthalmology 2015 Experimental Therapy Poland 36
    8051 Cord Tissue Allogeneic – Unrelated Cerebellar Ataxia Neurology 2015 Experimental Therapy Poland 18
    8052 Cord Tissue Allogeneic – Unrelated Cerebellar Ataxia Neurology 2015 Experimental Therapy Poland 26
    8053 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 3
    8054 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 15
    8055 Cord Tissue Allogeneic – Unrelated & Related Cerebral Palsy Neurology 2015 Experimental Therapy Poland 7
    8056 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 13
    8057 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 8
    8058 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 2
    8059 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 12
    8060 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 4
    8061 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 22
    8062 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 9
    8063 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 1
    8064 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 14
    8065 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2015 Experimental Therapy Poland 16
    8066 Cord Tissue Allogeneic – Unrelated Ceroid Lipofuscinosis Neurology 2015 Experimental Therapy Poland 5
    8067 Cord Tissue Allogeneic – Unrelated Ceroid Lipofuscinosis Neurology 2015 Experimental Therapy Poland 7
    8068 Cord Tissue Allogeneic – Unrelated Chronic Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 10
    8069 Cord Tissue Allogeneic – Unrelated Decerebration Rigidity Neurology 2015 Experimental Therapy Poland 9
    8070 Cord Tissue Allogeneic – Unrelated Delayed Psychomotor Development Neurology 2015 Experimental Therapy Poland 3
    8071 Cord Tissue Allogeneic – Unrelated Delayed Psychomotor Development, Deafness Neurology 2015 Experimental Therapy Poland 3
    8072 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2015 Experimental Therapy Poland 14
    8073 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2015 Experimental Therapy Poland 8
    8074 Cord Tissue Allogeneic – Unrelated & Related Encephalopathy Neurology 2015 Experimental Therapy Poland 11
    8075 Cord Tissue Allogeneic – Unrelated Facioscapulohumeral Muscular Dystrophy Neurology 2015 Experimental Therapy Poland 30
    8076 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2015 Experimental Therapy Poland 66
    8077 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2015 Experimental Therapy Poland 65
    8078 Cord Tissue Allogeneic – Unrelated Iatrogenic Spinal Cord Injury Neurology 2015 Experimental Therapy Poland 17
    8079 Cord Tissue Allogeneic – Unrelated Intracranial Injury Neurology 2015 Experimental Therapy Poland 24
    8080 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2015 Experimental Therapy Poland 18
    8081 Cord Tissue Allogeneic – Unrelated Optic Neuropathy Ophthalmology 2015 Experimental Therapy Poland 15
    8082 Cord Tissue Allogeneic – Unrelated Optic Neuropathy Ophthalmology 2015 Experimental Therapy Poland 45
    8083 Cord Tissue Allogeneic – Unrelated Polyneuropathy Neurology 2015 Experimental Therapy Poland 74
    8084 Cord Tissue Allogeneic – Unrelated Retinitis Pigmentosa Ophthalmology 2015 Experimental Therapy Poland 34
    8085 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2015 Experimental Therapy Poland 23
    8086 Cord Tissue Allogeneic – Unrelated Sclerosis Multiplex Neurology 2015 Experimental Therapy Poland 33
    8087 Cord Tissue Allogeneic – Unrelated Severe Developmental Delay Neurology 2015 Experimental Therapy Poland 1
    8088 Cord Tissue Allogeneic – Unrelated Spina Bifida Neurology 2015 Experimental Therapy Poland 2
    8089 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 31
    8090 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 18
    8091 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 40
    8092 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 26
    8093 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 37
    8094 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 32
    8095 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 21
    8096 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 24
    8097 Cord Tissue Allogeneic – Unrelated Spinal Cord Injury Orthopedy 2015 Experimental Therapy Poland 34
    8098 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2015 Experimental Therapy Poland 11
    8099 Cord Tissue Allogeneic – Unrelated Spinal Muscular Atrophy Neurology 2015 Experimental Therapy Poland 26
    8100 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2015 Experimental Therapy Poland 35